Literature DB >> 3020019

Regulation of uridine kinase. Evidence for a regulatory site.

N Cheng, R C Payne, T W Traut.   

Abstract

Uridine kinase from mouse Ehrlich ascites tumor cells may exist at 4 degrees C in multiple aggregation states that only slowly equilibrate with one another. Increasing the temperature leads to dissociation, and the appearance of a single predominant species: at 22 degrees C the enzyme exists as a tetramer. There is also a break in the dependence of enzyme activity on temperature as measured in an Arrhenius plot. The feedback inhibitors CTP and UTP cause the enzyme to dissociate to the monomer, whereas the substrate ATP reverses this process. Kinetic studies show that the monomer has little or no activity. Studies of the reaction mechanism show that binding of substrates is ordered, leading to a ternary complex, and release of products is ordered: uridine is the first substrate bound, ADP the first product released. Except for the inhibitors UTP and CTP, all other nucleoside triphosphates, whether purine or pyrimidine, or containing ribose or deoxyribose, act as phosphate donor. Especially interesting are the opposite effects of CTP and dCTP on uridine kinase: unlike CTP, dCTP does not dissociate the enzyme and is competent as a phosphate donor. We propose that the various effects of different ligands are best explained by the existence of a regulatory site (with more stringent specificity than the catalytic site) that controls dissociation of uridine kinase to the inactive monomer.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3020019

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Bioorthogonal Metabolic Labeling of Nascent RNA in Neurons Improves the Sensitivity of Transcriptome-Wide Profiling.

Authors:  Esmi L Zajaczkowski; Qiong-Yi Zhao; Zong Hong Zhang; Xiang Li; Wei Wei; Paul R Marshall; Laura J Leighton; Sarah Nainar; Chao Feng; Robert C Spitale; Timothy W Bredy
Journal:  ACS Chem Neurosci       Date:  2018-06-15       Impact factor: 4.418

Review 2.  Human pyrimidine nucleotide biosynthesis as a target for antiviral chemotherapy.

Authors:  Ayse Okesli; Chaitan Khosla; Michael C Bassik
Journal:  Curr Opin Biotechnol       Date:  2017-04-27       Impact factor: 9.740

3.  Sequencing cell-type-specific transcriptomes with SLAM-ITseq.

Authors:  Wayo Matsushima; Veronika A Herzog; Tobias Neumann; Katharina Gapp; Johannes Zuber; Stefan L Ameres; Eric A Miska
Journal:  Nat Protoc       Date:  2019-06-26       Impact factor: 13.491

Review 4.  The Metabolic and Non-Metabolic Roles of UCK2 in Tumor Progression.

Authors:  Yi Fu; Xin-Dong Wei; Luoting Guo; Kai Wu; Jiamei Le; Yujie Ma; Xiaoni Kong; Ying Tong; Hailong Wu
Journal:  Front Oncol       Date:  2022-05-20       Impact factor: 5.738

Review 5.  Physiological concentrations of purines and pyrimidines.

Authors:  T W Traut
Journal:  Mol Cell Biochem       Date:  1994-11-09       Impact factor: 3.396

6.  Blood-brain barrier efflux transport of pyrimidine nucleosides and nucleobases in the rat.

Authors:  Zoran B Redzic; Slava A Malatiali; James D Craik; Miodrag L Rakic; Aleksandra J Isakovic
Journal:  Neurochem Res       Date:  2008-08-27       Impact factor: 3.996

7.  Characterization of uridine-cytidine kinase like-1 nucleoside kinase activity and its role in tumor growth.

Authors:  Emily C Matchett; Elise C Ambrose; Jacki Kornbluth
Journal:  Biochem J       Date:  2022-06-17       Impact factor: 3.766

Review 8.  Substrate specificity and phosphorylation of antiviral and anticancer nucleoside analogues by human deoxyribonucleoside kinases and ribonucleoside kinases.

Authors:  An R Van Rompay; Magnus Johansson; Anna Karlsson
Journal:  Pharmacol Ther       Date:  2003-11       Impact factor: 12.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.